Serendip innovations

Develops a targeted antigen delivery system using plant-derived nanoparticles, enabling rapid, cost-effective production. The technology is based on modular particles capable of carrying various active ingredients (proteins, peptides, mRNAs) and specifically targeting immune cells, notably in therapeutic oncology vaccines. This approach optimizes the activation of immune responses against tumours, with simple, human pathogen-free production and high stability for practical use.